Created by fCoder Graphics Processor

Diebold Nixdorf Inc (NYSE:DBD)’s share price soared 2.28% or 0.4 to reach at $17.95 during previous trading session. A total of 1.04 Million shares exchanged hands, whereas the company’s average trading volume stands at 1.57 Million shares. Diebold Nixdorf Inc (NYSE:DBD) has a market capitalization of $1.36 Billion and most recently 75.8 Million outstanding shares have been calculated.

According to sentiments of 6 analysts the mean estimates of short term price target for the company’s stock is marked at $21.58. The most optimistic analyst sees the stock reaching $28 while the most conventional predicts the target price at $16.5.

In terms of Buy/Sell recommendations, 6 analysts have a consensus rating of 1.8 on the shares of Diebold Nixdorf Inc (NYSE:DBD). Out of rating recommendations 1 have given the stock a Buy while 3 recommend the stock as Outperform. 3 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Diebold Nixdorf Inc (NYSE:DBD)’s distance from 20 day simple moving average is 0.1361 along with distance from 50 day simple moving average of 16.62 whereas its distance from 200 day simple moving average is 18.81. Diebold Nixdorf Inc (NYSE:DBD)’s price distance from 52-week high is -42.1 and from 52-week low is 39.15. The stock hit its 52-week high price on 03/31/17, and 52-week low price on 02/13/18. The stock’s 52-week price fluctuated within the range of $31.00 – $12.90.

Diebold Nixdorf Inc (NYSE:DBD)’s shares climbed 4.97% in the past week and soared 13.25% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -11.36% while its year to date performance is at 9.79%.

While taking a glance at financials, we can look at a number of key indicators. Diebold Nixdorf Inc (NYSE:DBD) has a Return on Assets (ROA) of -4.4. The company currently has a Return on Equity (ROE) of -43.1 and a Return on Investment (ROI) of -1.4. Average true range (ATR-14) of the company sets at 0.87, along with its weekly and monthly volatility of 4.09% and 5.95% respectively. Relative strength index (RSI-14) for Diebold Nixdorf Inc (NYSE:DBD) is at 63.44. Beta value of the stock stands at 2.09.

The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 1 along with current ratio for most recent quarter of 1.4. Total debt to equity ratio of Diebold Nixdorf Inc (NYSE:DBD) for most recent quarter is 3.94 whereas long term debt to equity ratio for most recent quarter is 3.8.

Shares of Glycomimetics Inc (NASDAQ:GLYC) soared 5.83% or 1.04 to reach at $18.87 during previous trading session. Glycomimetics Inc (NASDAQ:GLYC) has a market capitalization of $652.34 Million and most recently 34.57 Million outstanding shares have been calculated. A total of 1.05 Million shares exchanged hands, whereas the company’s average trading volume stands at 874.37 Million shares.

According to 4 analysts Glycomimetics Inc (NASDAQ:GLYC)’s price will reach at $27 during 52 weeks. Stock’s minimum price target estimates has been figured out at $18 while the maximum price target forecast is established at $35.

According to the recommendations from 5 analysts stock has mean rating of 1 on the shares of Glycomimetics Inc (NASDAQ:GLYC). Out of rating recommendations 2 have given the stock a Buy while 3 recommend the stock as Outperform. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of Glycomimetics Inc (NASDAQ:GLYC) slipped -17.31% in the past week and plunged -14.34% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 69.39% while its year to date performance is at 12.39%.

Glycomimetics Inc (NASDAQ:GLYC)’s 52-week price fluctuated within the range of $26.05 – $3.82. Its price distance from 52-week high is -27.56 and from 52-week low is 393.98. The stock hit its 52-week high price on 02/15/18, and 52-week low price on 05/11/17. Glycomimetics Inc (NASDAQ:GLYC)’s distance from 20 day simple moving average is-0.1688 along with distance from 50 day simple moving average of 22.72 whereas its distance from 200 day simple moving average is 16.07.

Total debt to equity ratio of Glycomimetics Inc (NASDAQ:GLYC) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0. The company’s price to free cash flow for trailing twelve months is 0. Its quick ratio for most recent quarter is 17.4 along with current ratio for most recent quarter of 17.4.

Average true range (ATR-14) of the company sets at 1.84, along with its weekly and monthly volatility of 8.35% and 7.35% respectively. Relative strength index (RSI-14) for Glycomimetics Inc (NASDAQ:GLYC) is at 38.22. Beta value of the stock stands at 3.18. Glycomimetics Inc (NASDAQ:GLYC) has a Return on Assets (ROA) of -40.7. The company currently has a Return on Equity (ROE) of -44.3 and a Return on Investment (ROI) of 0.